Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02
针对儿童非T细胞急性淋巴细胞白血病(ALL)的风险调整疗法可改善标准风险患者的预后:JACLS ALL-02 研究结果
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-020-0287-4
Hasegawa, Daiichiro; Imamura, Toshihiko; Yumura-Yagi, Keiko; Takahashi, Yoshihiro; Usami, Ikuya; Suenobu, So-Ichi; Nishimura, Shinichiro; Suzuki, Nobuhiro; Hashii, Yoshiko; Deguchi, Takao; Moriya-Saito, Akiko; Kato, Koji; Kosaka, Yoshiyuki; Hirayama, Masahiro; Iguchi, Akihiro; Kawasaki, Hirohide; Hori, Hiroki; Sato, Atsushi; Kudoh, Tooru; Nakahata, Tatsutoshi; Oda, Megumi; Hara, Junichi; Horibe, Keizo